Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Foreign media: Eli Lilly is set to finalize the acquisition of biotech firm Ventyx for over $1 billion
On January 6, Eastern Time, The Wall Street Journal reported that Eli Lilly is close to finalizing a deal to acquire Ventyx, a company specializing in the development of drugs for inflammatory diseases, for more than $1 billion.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Recommended Reading


